BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26239638)

  • 1. Editorial: Combination Therapy of Vascular Diseases and Fangjiomics: When West Meets East in the Era of Phenomics.
    Wang Z; Duan DD; Wang YY
    Curr Vasc Pharmacol; 2015; 13(4):420-2. PubMed ID: 26239638
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenomics of Vascular Disease: The Systematic Approach to the Combination Therapy.
    Han Y; Li L; Zhang Y; Yuan H; Ye L; Zhao J; Duan DD
    Curr Vasc Pharmacol; 2015; 13(4):433-40. PubMed ID: 25313004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine.
    Duan DD; Wang Z; Zhang BL; Wang YY
    Acta Pharmacol Sin; 2015 Jun; 36(6):651-3. PubMed ID: 26036241
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of peripheral vascular diseases with Chinese medicine].
    Lin ZG
    Zhong Xi Yi Jie He Za Zhi; 1984 Sep; 4(9):570-1. PubMed ID: 6240354
    [No Abstract]   [Full Text] [Related]  

  • 5. Fangjiomics: in search of effective and safe combination therapies.
    Wang Z; Liu J; Cheng Y; Wang Y
    J Clin Pharmacol; 2011 Aug; 51(8):1132-51. PubMed ID: 21209238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision oncology: East meets West.
    Subbiah V; Rodon J; Yap TA
    Int J Cancer; 2018 May; 142(9):1734-1737. PubMed ID: 29243227
    [No Abstract]   [Full Text] [Related]  

  • 7. [Microcirculatory disturbances in relation to "blood stasis symptoms" and "activating blood and relieving stasis"].
    Jin HM
    Zhong Xi Yi Jie He Za Zhi; 1982 Jul; 2(3):182-4. PubMed ID: 6219827
    [No Abstract]   [Full Text] [Related]  

  • 8. [34 cases of peripheral vascular disease treated with activating blood circulation and correcting stasis].
    Wang JY; Zhang YW
    Zhong Xi Yi Jie He Za Zhi; 1985 May; 5(5):269-270, 259. PubMed ID: 3159494
    [No Abstract]   [Full Text] [Related]  

  • 9. Ushering Hypertension Into a New Era of Precision Medicine.
    Kotchen TA; Cowley AW; Liang M
    JAMA; 2016 Jan; 315(4):343-4. PubMed ID: 26769233
    [No Abstract]   [Full Text] [Related]  

  • 10. Precision medicine?
    Koea JB
    ANZ J Surg; 2017 Apr; 87(4):218-219. PubMed ID: 28371037
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research on Precision Medicine, Gene Polymorphism, and Combination of Disease Identification and Syndrome Typing on Cardiovascular Diseases].
    Xue M; Shi DZ; Chen KJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Oct; 36(10):1255-1260. PubMed ID: 30641016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. East Meets West: Synergy through Diversity.
    Hager S; Dai J; Fischer V; Lüthke F; Staudinger A
    Forsch Komplementmed; 2016; 23 Suppl 2():3-7. PubMed ID: 27272152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 14. East meets West.
    Chow E
    Calif Nurse; 1984 Dec-1985 Jan; 80(10):8-9. PubMed ID: 6568836
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine.
    Hainsworth JD; Greco FA
    Am Soc Clin Oncol Educ Book; 2018 May; 38():20-25. PubMed ID: 30231392
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy.
    Kzhyshkowska J; Bizzarri M; Apte R; Cherdyntseva N
    Curr Pharm Des; 2017; 23(32):4703-4704. PubMed ID: 29283049
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimizing Combination Therapy for Acute Lymphoblastic Leukemia Using a Phenotypic Personalized Medicine Digital Health Platform: Retrospective Optimization Individualizes Patient Regimens to Maximize Efficacy and Safety.
    Lee DK; Chang VY; Kee T; Ho CM; Ho D
    SLAS Technol; 2017 Jun; 22(3):276-288. PubMed ID: 27920397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Medicine for Diffuse Large B-cell Lymphoma.
    Lim MS; Elenitoba-Johnson KS
    Clin Cancer Res; 2016 Jun; 22(12):2829-31. PubMed ID: 26988247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 20. [New era of laboratory testing. Topics: I. Generals; 4. Role of laboratory tests in personalized medicine].
    Nakatani K
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3103-9. PubMed ID: 24605557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.